Philips Tops Clarivate’s 2025 List of Global Innovators
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been lauded for its commitment to innovation. Clarivate has named Philips as the top-ranked medical technology company in its Top 100 Global Innovators 2025 report. This marks the 12th consecutive year that Philips has been included in this prestigious ranking, solidifying its position as a leading innovator in the healthcare industry.
Roy Jakobs, CEO of Royal Philips, stated that “At Philips, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people.”
The Azurion image-guided therapy system.
Philips consistently invests a significant portion of its revenue in research and development. In 2024, the company allocated approximately EUR 1.7 billion – over 9% of its sales – to R&D initiatives. A considerable portion of Philips’ innovation efforts are directed towards the potential of data and artificial intelligence in both hospital and home settings. Philips is a leader in AI-related patent applications in healthcare, dedicating roughly half of its R&D workforce to these fields.
Several of Philips’ AI-powered innovations are designed to enhance caregiver productivity and improve patient care, including:
- The Philips CT 5300, integrating hardware, software, and AI to enable high-quality imaging.
- The SmartSpeed Precise MRI technology, which reduces scan times while maintaining image quality.
- A next-generation AI-enabled cardiovascular ultrasound platform with advanced AI tools to enhance cardiovascular imaging.
- The Azurion image-guided therapy system and informatics to advance minimally invasive diagnosis and treatment.
The Clarivate Top 100 Global Innovators report uses a comprehensive analysis of global invention data to measure the strength of each patented idea, directly reflecting their innovative impact.
